{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:05:37Z","timestamp":1791353137987,"version":"4.3.1"},"reference-count":121,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.semcancer.2013.08.001","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T21:46:40Z","timestamp":1377294400000},"page":"23-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["The yin and the yang of follicular lymphoma cell niches: Role of microenvironment heterogeneity and plasticity"],"prefix":"10.1016","volume":"24","author":[{"given":"Patricia","family":"Am\u00e9-Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Tarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2013.08.001_bib0005","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1172\/JCI63186","article-title":"Pathogenesis of follicular lymphoma","volume":"122","author":"Kridel","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0010","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"25","author":"Montoto","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev-immunol-020711-075027","article-title":"Pathogenesis of human B cell lymphomas","volume":"30","author":"Shaffer","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-385991-4.00001-5","article-title":"Early steps of follicular lymphoma pathogenesis","volume":"111","author":"Roulland","year":"2011","journal-title":"Adv Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0025","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","article-title":"Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma","volume":"121","author":"Green","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2141.2009.07651.x","article-title":"The Germinal centre-derived lymphomas seen through their cellular microenvironment","volume":"145","author":"Carbone","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0035","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2141.2002.03497.x","article-title":"The stromal composition of malignant lymphoid aggregates in bone marrow: variations in architecture and phenotype in different B-cell tumours","volume":"117","author":"Vega","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0040","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1038\/bcj.2011.53","article-title":"Entourage: the immune microenvironment following follicular lymphoma","volume":"2","author":"Wahlin","year":"2012","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0045","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1111\/j.1365-2559.2012.04187.x","article-title":"Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma","volume":"60","author":"Rajnai","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0050","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.leu.2403844","article-title":"Clonal selection in the bone marrow involvement of follicular lymphoma","volume":"19","author":"Bognar","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0055","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood-2007-11-124560","article-title":"S(mu) mutation patterns suggest different progression pathways in follicular lymphoma: early direct or late from FL progenitor cells","volume":"112","author":"Ruminy","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0060","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2012.074252","article-title":"Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse","author":"Wartenberg","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0065","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/leu.2011.266","article-title":"High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis","volume":"26","author":"Launay","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0070","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.coph.2012.03.001","article-title":"The HVEM network: new directions in targeting novel costimulatory\/co-inhibitory molecules for cancer therapy","volume":"12","author":"Pasero","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0075","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1182\/blood-2011-11-367730","article-title":"Follicular lymphoma and the immune system: from pathogenesis to antibody therapy","volume":"119","author":"Stevenson","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0080","doi-asserted-by":"crossref","first-page":"18587","DOI":"10.1073\/pnas.1009388107","article-title":"Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins","volume":"107","author":"Coelho","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0085","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1200\/JCO.2009.26.1693","article-title":"Prognostic factors in follicular lymphoma","volume":"28","author":"Relander","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0090","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1182\/blood-2008-06-165654","article-title":"Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study","volume":"113","author":"Di Nicola","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0100","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1182\/blood-2008-10-185280","article-title":"Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a vaccinal effect of rituximab","volume":"113","author":"Hilchey","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0105","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nrc2717","article-title":"Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures","volume":"9","author":"Bendandi","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0110","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","article-title":"The natural history of initially untreated low-grade non-Hodgkin's lymphomas","volume":"311","author":"Horning","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0115","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1200\/JCO.2006.06.4766","article-title":"Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients","volume":"24","author":"Alvaro","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0120","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1158\/1078-0432.CCR-11-0264","article-title":"T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab","volume":"17","author":"Wahlin","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0125","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1182\/blood-2011-04-345777","article-title":"Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study","volume":"118","author":"Laurent","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0130","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI59806","article-title":"IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma","volume":"122","author":"Yang","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0135","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1182\/blood-2009-04-217687","article-title":"Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy","volume":"114","author":"Ramsay","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0140","doi-asserted-by":"crossref","first-page":"10145","DOI":"10.1158\/0008-5472.CAN-06-1822","article-title":"Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.2006.06.1648","article-title":"Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma","volume":"25","author":"Glas","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12026-011-8231-0","article-title":"Natural killer (NK): dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity","volume":"50","author":"Lee","year":"2011","journal-title":"Immunol Res"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0155","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3324\/haematol.2010.029520","article-title":"gammadelta T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody","volume":"96","author":"Braza","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0160","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1182\/blood-2003-04-1016","article-title":"Flexible migration program regulates gamma delta T-cell involvement in humoral immunity","volume":"102","author":"Brandes","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0165","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4049\/jimmunol.0901980","article-title":"gammadelta T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes","volume":"184","author":"Braza","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0170","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2012-11-464685","article-title":"The co-receptor BTLA negatively regulates human Vgamma9Vdelta2T cell proliferation: a potential way of immune escape for lymphoma cells","author":"Gertner-Dardenne","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0175","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1182\/blood-2006-06-028985","article-title":"Expansion of Vdelta1T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins","volume":"109","author":"Catellani","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0180","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0185","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","article-title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","volume":"106","author":"Farinha","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0190","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1200\/JCO.2007.12.8298","article-title":"High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial","volume":"26","author":"Canioni","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0195","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1158\/1078-0432.CCR-07-0778","article-title":"A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide\u2013doxorubicin\u2013vincristine\u2013prednisone","volume":"13","author":"Taskinen","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0200","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2008-01-135160","article-title":"Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV","volume":"112","author":"Minard-Colin","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0205","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1182\/blood-2002-02-0469","article-title":"In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas","volume":"101","author":"Manches","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0210","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.4049\/jimmunol.1202588","article-title":"Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties","volume":"190","author":"Rafiq","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0215","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.0713732","article-title":"M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro","volume":"182","author":"Leidi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0220","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1189\/jlb.0904532","article-title":"Cytokine-mediated regulation of activating and inhibitory Fc gamma receptors in human monocytes","volume":"77","author":"Liu","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0225","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/leu.2010.223","article-title":"Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH-B cell axis","volume":"24","author":"Pangault","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0230","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2010.07.044","article-title":"Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma","volume":"142","author":"Chao","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0235","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood-2012-06-440354","article-title":"Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment","volume":"121","author":"Yamauchi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0240","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1158\/1078-0432.CCR-07-4405","article-title":"Lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells","volume":"14","author":"Wu","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0245","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/leu.2012.119","article-title":"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide","volume":"26","author":"Lopez-Girona","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0250","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood-2012-08-448332","article-title":"Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide","volume":"121","author":"Ramsay","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0255","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.yexcr.2011.03.018","article-title":"Modulation of antibody effector function","volume":"317","author":"Desjarlais","year":"2011","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0260","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1158\/1535-7163.MCT-08-0201","article-title":"Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells","volume":"7","author":"Richards","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0265","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.it.2011.07.003","article-title":"Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy","volume":"32","author":"Houot","year":"2011","journal-title":"Trends Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0270","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood-2010-08-301945","article-title":"CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies","volume":"117","author":"Kohrt","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0275","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2009-02-206532","article-title":"Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells","volume":"114","author":"Romagne","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0280","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bjh.12090","article-title":"Anti-tumour immunotherapy with Vgamma9Vdelta2T lymphocytes: from the bench to the bedside","volume":"160","author":"Braza","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0285","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0290","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nri2588","article-title":"Stromal cell contributions to the homeostasis and functionality of the immune system","volume":"9","author":"Mueller","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0295","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-immunol-031210-101357","article-title":"Stromal cell-immune cell interactions","volume":"29","author":"Roozendaal","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0300","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1182\/blood-2006-05-020800","article-title":"Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis","volume":"109","author":"Am\u00e9-Thomas","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0305","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0002-9440(10)63640-1","article-title":"Phenotypic modulation of the stromal reticular network in normal and neoplastic lymph nodes: tissue transglutaminase reveals coordinate regulation of multiple cell types","volume":"163","author":"Thomazy","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0310","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/path.1478","article-title":"Germinal centre-like versus undifferentiated stromal immunophenotypes in follicular lymphoma","volume":"201","author":"Chang","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0315","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2559.2011.03779.x","article-title":"Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome","volume":"58","author":"Jin","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0320","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1182\/blood-2011-08-370908","article-title":"Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes","volume":"119","author":"Guilloton","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0325","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1365-2141.2002.03832.x","article-title":"CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells","volume":"119","author":"Husson","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0330","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/his.12035","article-title":"Expression of multidrug resistance 1 gene in B-cell lymphomas: association with follicular dendritic cells","volume":"62","author":"Yagi","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0335","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.4049\/jimmunol.174.3.1456","article-title":"Sonic hedgehog is produced by follicular dendritic cells and protects germinal center B cells from apoptosis","volume":"174","author":"Sacedon","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0340","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm1614","article-title":"Essential role of stromally induced hedgehog signaling in B-cell malignancies","volume":"13","author":"Dierks","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0345","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.4049\/jimmunol.173.11.6676","article-title":"Follicular dendritic cells produce IL-15 that enhances germinal center B cell proliferation in membrane-bound form","volume":"173","author":"Park","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0350","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/leu.2011.179","article-title":"Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling","volume":"26","author":"Epron","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0355","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.4049\/jimmunol.175.5.2807","article-title":"Follicular dendritic cells catalyze hepatocyte growth factor (HGF) activation in the germinal center microenvironment by secreting the serine protease HGF activator","volume":"175","author":"Tjin","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0360","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1182\/blood-2005-05-1929","article-title":"Functional analysis of HGF\/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma","volume":"107","author":"Tjin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0365","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1189\/jlb.0706481","article-title":"Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation","volume":"82","author":"Mueller","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0370","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/leu.2008.266","article-title":"Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis","volume":"23","author":"Lwin","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0375","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/leu.2010.35","article-title":"Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation","volume":"24","author":"Singh","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0380","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2141.2011.08794.x","article-title":"Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin alpha-4-beta-1 (VLA-4) with natalizumab can overcome this resistance","volume":"155","author":"Mraz","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0385","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI66517","article-title":"BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression","volume":"123","author":"Roccaro","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0390","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ncb2432","article-title":"Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia","volume":"14","author":"Zhang","year":"2012","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0395","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.stem.2012.08.013","article-title":"CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFalpha","volume":"11","author":"Ren","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0400","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-08-3000","article-title":"Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase","volume":"69","author":"Maby-El Hajjami","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0405","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/ni.2112","article-title":"Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes","volume":"12","author":"Lukacs-Kornek","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0410","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2012-04-421826","article-title":"High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells","volume":"121","author":"Myklebust","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0415","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1182\/blood-2011-03-340646","article-title":"Follicular lymphoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T(H) cells despite skewed differentiation","volume":"118","author":"Hilchey","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0420","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.immuni.2009.03.003","article-title":"Follicular helper T cells: lineage and location","volume":"30","author":"Fazilleau","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0425","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/leu.2011.301","article-title":"Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells","volume":"26","author":"Am\u00e9-Thomas","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0430","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2008-02-138933","article-title":"IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma","volume":"112","author":"Calvo","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0435","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4049\/jimmunol.181.2.1001","article-title":"CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL","volume":"181","author":"Travert","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0440","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1101\/gad.1874010","article-title":"IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion","volume":"24","author":"Gocheva","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0445","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1182\/blood-2005-08-3376","article-title":"Intratumoral CD4+ CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma","volume":"107","author":"Yang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0450","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood-2011-03-340885","article-title":"Soluble IL-2Ralpha facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma","volume":"118","author":"Yang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0455","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2009-07-235598","article-title":"The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation","volume":"115","author":"Farinha","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0460","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.4049\/jimmunol.180.5.2967","article-title":"Expression of ICOS on human melanoma-infiltrating CD4+ CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression","volume":"180","author":"Strauss","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0465","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.2425","article-title":"Foxp3+ follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0470","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1182\/blood-2004-02-0762","article-title":"Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome","volume":"104","author":"Novak","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0475","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1158\/0008-5472.CAN-08-4915","article-title":"Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma","volume":"69","author":"Novak","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0480","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1084\/jem.20100857","article-title":"A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling","volume":"207","author":"Hildebrand","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0485","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1182\/blood-2012-05-427534","article-title":"Self-antigen recognition by follicular lymphoma B-cell receptors","volume":"120","author":"Sachen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0490","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.4049\/jimmunol.1000475","article-title":"Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10","volume":"186","author":"Dominguez-Soto","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0495","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.1073\/pnas.0902637106","article-title":"Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0500","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.4049\/jimmunol.175.6.3637","article-title":"IFN-gamma-primed macrophages exhibit increased CCR2-dependent migration and altered IFN-gamma responses mediated by Stat1","volume":"175","author":"Hu","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0505","first-page":"1605","article-title":"The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma","volume":"91","author":"Alvaro","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0510","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/leu.2008.380","article-title":"The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages","volume":"23","author":"Carbonnelle-Puscian","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0515","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1182\/blood-2009-11-253260","article-title":"Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting micro-environment","volume":"115","author":"Clear","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0520","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2010-05-283820","article-title":"Immunosuppressive CD14+ HLA-DR(low)\/\u2212 monocytes in B-cell non-Hodgkin lymphoma","volume":"117","author":"Lin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0525","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/10428194.2011.637211","article-title":"The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma","volume":"53","author":"Wilcox","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0530","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/10428194.2011.601698","article-title":"Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists","volume":"53","author":"Hu","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0535","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2011-04-347518","article-title":"Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia","volume":"119","author":"O\u2019Callaghan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0540","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1182\/blood-2011-11-390989","article-title":"The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia","volume":"119","author":"de Rooij","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0545","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2011-05-352492","article-title":"The phosphoinositide 3\u2032-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia","volume":"118","author":"Hoellenriegel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0550","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/leu.2012.24","article-title":"Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration","volume":"26","author":"Hoellenriegel","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0555","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.exphem.2012.06.004","article-title":"Impact of lenalidomide on the functional properties of human mesenchymal stromal cells","volume":"40","author":"Wobus","year":"2012","journal-title":"Exp Hematol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0560","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1182\/blood-2011-12-395939","article-title":"RhoH is critical for cell\u2013microenvironment interactions in chronic lymphocytic leukemia in mice and humans","volume":"119","author":"Troeger","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0565","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1182\/blood-2013-03-490763","article-title":"Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes","volume":"121","author":"Ruan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0570","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/1078-0432.CCR-12-2063","article-title":"Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer","volume":"19","author":"Sznol","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0575","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2496","article-title":"The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood","volume":"14","author":"Sage","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0580","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nm.3109","article-title":"Inadequate T follicular cell help impairs B cell immunity during HIV infection","volume":"19","author":"Cubas","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0585","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1158\/0008-5472.CAN-09-0266","article-title":"Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma","volume":"69","author":"Yang","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0590","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1182\/blood-2007-03-082578","article-title":"CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+ CD25 T cells","volume":"110","author":"Yang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0595","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2012-02-411678","article-title":"Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer","volume":"120","author":"Ramsay","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0600","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00281-009-0194-z","article-title":"Signals that influence T follicular helper cell differentiation and function","volume":"32","author":"Linterman","year":"2010","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.semcancer.2013.08.001_bib0605","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature12058","article-title":"Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility","volume":"496","author":"Xu","year":"2013","journal-title":"Nature"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X13000771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X13000771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T21:42:09Z","timestamp":1563745329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X13000771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":121,"alternative-id":["S1044579X13000771"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2013.08.001","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The yin and the yang of follicular lymphoma cell niches: Role of microenvironment heterogeneity and plasticity","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2013.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}